by admin | Feb 27, 2026 | press-releases
Home CG Oncology Reports… PRESS RELEASE CG Oncology Reports 2025 Year End Financial Results and Provides Business Updates Listen to this article now PIVOT-006 Phase 3 topline data evaluating cretostimogene monotherapy as an adjuvant therapy in intermediate-risk...
by admin | Feb 23, 2026 | press-releases
Home PRESS RELEASE CG Oncology to Present at the TD Cowen 46th Annual Health Care Conference Listen to this article now IRVINE, Calif., February 23, 2026 (GLOBE NEWSWIRE) — CG Oncology, Inc. (NASDAQ: CGON) today announced that Arthur Kuan, Chairman & Chief...
by admin | Jan 9, 2026 | press-releases
Home PRESS RELEASE CG Oncology Provides Updated Timeline for PIVOT-006 Phase 3 Topline Data in Intermediate-Risk NMIBC 💻 DESKTOP AUDIO PLAYER =============================== --> Listen to this article now 0:00 📱 MOBILE AUDIO PLAYER =============================== -->...
by admin | Jan 6, 2026 | press-releases
Home CG Oncology to Present… PRESS RELEASE CG Oncology to Present at the 44th Annual J.P. Morgan Healthcare Conference 💻 DESKTOP AUDIO PLAYER =============================== --> Listen to this article now 0:00 📱 MOBILE AUDIO PLAYER =============================== -->...
by admin | Dec 18, 2025 | press-releases
Home PRESS RELEASE SUO-CTC and CG Oncology Announce the Second Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award 💻 DESKTOP AUDIO PLAYER =============================== --> Listen to this article now 0:00 📱 MOBILE AUDIO PLAYER...
by admin | Dec 5, 2025 | press-releases
Home PRESS RELEASE New Cretostimogene Grenadenorepvec Data Highlight its Potential to Become the Backbone Therapy for High-Risk Non-Muscle Invasive Bladder Cancer 💻 DESKTOP AUDIO PLAYER =============================== --> Listen to this article now 0:00 📱 MOBILE AUDIO...